Russia announced Tuesday that it has approved a vaccine for COVID-19 and has plans to inoculate health care workers, teachers, and others in the coming months, despite barely starting Phase 3 clinical trials. Axios Re:Cap producer Naomi Shavin digs into the impacts of this announcement on the vaccine race with Derek Lowe, medicinal chemist, author and expert on drug development and the pharmaceutical industry.